NantHealth’s Eviti Platform Once More Earns Full URAC Accreditation Through 2025
The designation demonstrates the highest level of commitment to quality healthcare
NantHealth Inc., a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, announced it has been granted full URAC accreditation for Health Utilization Management for its Eviti Connect platform for another three years. NantHealth’s utilization management procedures have been accredited by URAC since 2010. This latest recognition extends URAC accreditation through September 1, 2025.
“NantHealth is honored to have attained full reaccreditation from URAC for Health Utilization Management”
Read More: ServicePath Deepens Microsoft Partnership – ServicePath CPQ+ Now Available Through Microsoft…
URAC is a Washington, DC-based nonprofit organization that helps promote healthcare quality through the accreditation of organizations involved in medical care services, as well as offering education and measurement programs. The URAC accreditation process validates compliance with nationally recognized, evidence-based standards and supports improvements and innovation in healthcare management and delivery. URAC’s Health Utilization Management Accreditation ensures that organizations conducting utilization reviews follow a process that is clinically and operationally sound and respects patients, providers, and payers.
In earning this status, NantHealth has continued to demonstrate its commitment to quality and health utilization management accountability in its quest to facilitate the best possible outcomes for patients.
Read More: SalesTechStar Interview with Kerry Cunningham, Research and Thought Leadership at 6sense
“We applaud NantHealth on achieving URAC accreditation. With this distinction, NantHealth demonstrates excellence in quality health care delivery and their commitment to ensuring patient safety,” said URAC President and CEO, Shawn Griffin, M.D.
“NantHealth is honored to have attained full reaccreditation from URAC for Health Utilization Management,” said Ron Louks, NantHealth’s chief operating officer. “We strive to hold ourselves to the highest possible standards and are committed to validating evidence-based medicine to improve patient outcomes and enable the highest quality healthcare possible.”
NantHealth’s Eviti Connect is a web-based application that directly connects health plans and practices to streamline treatment authorization for oncology and autoimmune conditions, certifying the application of quality, high-value care and setting patients on the path to appropriate treatment sooner. This powerful tool provides a comprehensive evidence-based solution that helps to ensure appropriate, cost-effective treatments to meet the health plan’s reimbursement requirements.
